Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?

Tidsskr Nor Laegeforen. 2020 May 14;140(9). doi: 10.4045/tidsskr.20.0411. Print 2020 Jun 16.
[Article in English, Norwegian]
No abstract available

MeSH terms

  • Angiotensin Receptor Antagonists* / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections* / complications
  • Humans
  • Pandemics*
  • Pneumonia, Viral* / complications
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors